You have 9 free searches left this month | for more free features.

Vesanoid

Showing 1 - 25 of 27

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Melanoma Trial in Aurora (VESANOID, Ipilimumab)

Active, not recruiting
  • Melanoma
  • Aurora, Colorado
    University of Colorado Hospital
Sep 7, 2022

Effect of Drug Trial in Taichung (Nivolumab, all trans retinoic acid)

Completed
  • Effect of Drug
  • Taichung, Please Select, Taiwan
    China Medical University Hospital
Jul 28, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Adelaide (IMG-7289, All-trans retinoic acid)

Completed
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Adelaide, South Australia, Australia
    Royal Adelaide Hospital
Jan 24, 2022

Promyelocytic Leukemia Trial in Monterrey (Arsenic trioxide, all-trans retinoic acid)

Recruiting
  • Promyelocytic Leukemia
  • Arsenic trioxide
  • all-trans retinoic acid
  • Monterrey, Nuevo Leon, Mexico
    Hopsital Universitario Dr. Jose E. Gonzalez, Centro Universitari
Aug 9, 2022

Acute Myeloid Leukemia Trial in United States (TAS1440, TAS1440 + ATRA)

Recruiting
  • Acute Myeloid Leukemia
  • Tucson, Arizona
  • +8 more
Jan 3, 2023

Breast Cancer Female Trial (All trans-retinoic acid, 13-Cis Retinoic Acid plus Tocopherol, Mifepristone)

Not yet recruiting
  • Breast Cancer Female
  • All trans-retinoic acid
  • +6 more
  • (no location specified)
Aug 17, 2021

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 27, 2022

Acute Myeloid Leukemia Trial in Regensburg (low-dose Azacitidine, Pioglitazone, ATRA)

Terminated
  • Acute Myeloid Leukemia
  • low-dose Azacitidine
  • +3 more
  • Regensburg, Germany
    University Hospital Regensburg
Nov 3, 2020

Melanoma Trial in Worldwide (Pembrolizumab, Vibostolimab, V937)

Recruiting
  • Melanoma
  • Pembrolizumab
  • +5 more
  • Los Angeles, California
  • +28 more
Jan 25, 2023

Melanoma Trial in Worldwide (Pembrolizumab, Quavonlimab, Vibostolimab)

Recruiting
  • Melanoma
  • Pembrolizumab
  • +4 more
  • Los Angeles, California
  • +34 more
Jan 25, 2023

Pancreatic Cancer Trial (ATRA, Gemcitabine, nab-paclitaxel)

Not yet recruiting
  • Pancreatic Cancer
  • (no location specified)
Jan 24, 2020

Pancreatic Adenocarcinoma Trial in Cambridge, London (ATRA, Gemcitabine, Nab-paclitaxel)

Completed
  • Pancreatic Adenocarcinoma
  • Cambridge, United Kingdom
  • +3 more
Jan 20, 2020

Breast Tumor Female Trial in Bergamo (all-trans retinoic acid, Anastrozole 1mg)

Unknown status
  • Breast Neoplasm Female
  • all-trans retinoic acid
  • Anastrozole 1mg
  • Bergamo, Italy
    ASST Papa Giovanni XXIII
Oct 3, 2019

Small Cell Lung Cancer Trial in Tampa (Paclitaxel, Drug: Ad.p53-DC vaccines, All -trans Retinoic Acid (ATRA))

Completed
  • Small Cell Lung Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
Nov 6, 2019

Acute Promyelocytic Leukemia Trial in Canada, United States (Tretinoin and Arsenic Trioxide)

Completed
  • Acute Promyelocytic Leukemia
  • Tretinoin and Arsenic Trioxide
  • Los Angeles, California
  • +11 more
Nov 2, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Germany (tranylcypromine, all-trans retinoic acid, cytarabine)

Unknown status
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Heidelberg, Baden-Wuerttemberg, Germany
  • +5 more
Oct 16, 2018

Myeloma Trial in Houston (Lenalidomide, Dexamethasone, All-Trans Retinoic Acid (ATRA))

Terminated
  • Myeloma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 12, 2016

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Pittsburgh (dasatinib (SPRYCEL), all trans retinoic acid

Completed
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • dasatinib (SPRYCEL)
  • all trans retinoic acid (VESANOID)
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute - Hillman Cancer Cente
Feb 9, 2016

Acute Myeloid Leukemia Trial in France (Vesanoid (ATRA), AZACITIDINE (VIDAZA), CYTARABINE)

Withdrawn
  • Acute Myeloid Leukemia
  • Vesanoid (ATRA)
  • +2 more
  • Amiens, France
  • +25 more
Dec 29, 2015

AML Trial in Halle (Tranylcypromine, Tretinoin)

Unknown status
  • AML
  • Halle, Germany
    Universitaetsklinikum Halle
Jul 6, 2015

Lung Cancer Trial in Lakewood (cisplatin, mitomycin C, tretinoin)

Unknown status
  • Lung Cancer
  • Lakewood, California
    Rajendra Prasad M.D., Inc.
Dec 17, 2013

Kidney Cancer Trial in Tampa (IL-2, ATRA)

Completed
  • Kidney Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 15, 2013

Lung Cancer Trial in Tampa (Vaccine Treatment, Cyclophosphamide, All-trans retinoic acid (ATRA))

Completed
  • Lung Cancer
  • Vaccine Treatment
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
May 15, 2013

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Saint Louis (arsenic trioxide, tretinoin)

Terminated
  • Leukemia
  • +3 more
  • Saint Louis, Missouri
    Washington University Barnard Cancer Center
Feb 4, 2013

Myelodysplastic Syndrome, Acute Myelogenous Leukemia Trial in Houston (5-Azacytidine (5-aza), Valproic Acid, All-Trans Retinoic

Completed
  • Myelodysplastic Syndrome
  • Acute Myelogenous Leukemia
  • 5-Azacytidine (5-aza)
  • +2 more
  • Houston, Texas
    The University of Texas M.D. Anderson Cancer Center
Jun 12, 2012